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ABSTRACT 
 
Pulmonary diffusing capacity for nitric oxide (DLNO) is a relatively new pulmonary 
function test to assess gas transfer in the lung. To date, there are no prediction equations made 
for healthy adult African-American (black) subjects.  Thus, the purpose of this study was to 
create prediction equations for DLNO in this ethnic/racial group.  A total of 59 healthy subjects 
(27 males and 32 females) were recruited to perform pulmonary function testing at Georgia State 
University. They were diverse in age (18-67 yr), height (140-189 cm), and body mass index 
(17.2-32.3 kg/m2). All subjects completed single-breath maneuvers at rest inhaling 43 ± 4 ppm 
NO with a standard diffusion mixture. The breath-hold duration was 5.6 ± 0.6 s. Multiple linear 
regression predicted DLNO based on the subject’s age, height, and sex. The prediction equation 
for DLNO (mL/min/mmHg) = 0.92·(height in cm) +38.8·(sex) – 0.012·(age2) – 25, where 1 = 
male, 0 = female for sex. About 77% of the variance in DLNO was accounted for by sex (67%), 
age2 (7%), and height (4%). The standard error of the estimate in predicting DLNO was 16.3 
mL/min/mmHg. Those with higher resting heart rates had a lower DLNO (r =-0.28, p = 0.03) but 
it was not included in the regression model as it did not enhance the fit. Black males had a 7-10% 
lower DLNO and black females had a 12-15% lower DLNO compared to matched white 
subjects.  Black males of the same age and height had a 10% smaller alveolar volume, while 
black females had a 15% lower alveolar volume compared to matched white subjects.  In 
conclusion, DLNO values and alveolar volumes are reduced in blacks compared to matched 
whites. The regression model presented best predicts DLNO in African-Americans below 40 
years of age. 
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CHAPTER I  
INTRODUCTION 
 
Pulmonary function tests (PFTs) are essential tools in today’s routine clinical assessment of 
respiratory function. They are used in the evaluation of patients with respiratory symptoms and 
for guiding the management of diagnosed lung disease. Without the guidance of PFTs, large 
number of patients get misdiagnosed and improperly treated.  One such pulmonary function test, 
otherwise known as pulmonary diffusing capacity for carbon monoxide (DLCO), was established 
in 1957 [1].  Since 1957, the single-breath DLCO test has become the clinical standard to assess 
gas transfer through the alveolar-capillary membrane.  Historically, prediction equations have 
been made for DLCO, but not DLNO.  Prediction equations are necessary for deciphering 
between normal and abnormal gas transfer through the lung and is usually based on the sex, 
height, and age, and sometimes the racial backgound of the subject.  These equations have been 
created for adults [2-7] and children [8, 9], with a wide range of racial backgrounds [10-17].  
Two abstracts were published in the early 1980’s examining the use of nitric oxide as a 
transfer gas through the alveolar-capillary membrane [18, 19]. These abstracts resulted in the 
first publications of DLNO in the late 1980s [20, 21].  Since, then several studies have been 
published demonstrating its superiority compared to the DLCO test. The chief barrier to CO 
uptake (~70-80%) resides within the red cell while ~25% is located in the alveolar membrane 
(See Figure 1 elsewhere [22]).  The main advantage of using NO as a transfer gas is that the main 
barrier for NO uptake resides between the alveolar and red blood cell membranes (~60%) [23].  
This advantage gives DLNO a better representation of gas transfer through the alveolar-capillary 
membrane compared to DLCO. Unlike DLCO, the DLNO is unaffected by changes in 
hemoglobin concentration [24], carboxyhemoglobin concentration [25], alveolar oxygen pressure 
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(PAO2) or inspired oxugen concentration [26, 27]. DLNO is more affected by lung volume 
compared to the DLCO which makes the KNO (mathematically, DLNO divided by alveolar 
volume) a better measure than the KCO (mathematically, DLCO divided by alveolar volume) in 
those with restrictive lung disease [22]. Finally, the sensitivity in detecting cardipulmonary 
disease is better using DLNO compared to DLCO [28]. These examples demonstarate there is 
evidence that the DLNO test is techinically and physiologically superior than the DLCO test 
[28].  
To date there has been few prediction equations developed for single-breath DLNO in 
adults [29-32] and children [33, 34]. One study has combined data from three studies to create a 
more accruate prediction model on nearly 500 white subjects [22]. However, no prediction 
equations for DLNO have been developed in the African-American population (herein known as 
the black population).   
There are ethnic/racial differences in certain aspects of lung function.  For example, 15% 
of the variability in vital capacity is accounted for by race/ethnicity [35].  In a black population,  
vital capacity (i.e. lung volume) is about 15% lower in blacks compared to age, height, and sex 
matched whites [11, 36], and the DLCO is also lower in blacks compared to matched whites [11, 
17].  Specifically, DLCO is lower by ~2 (~6%) and ~5 (~15%) mL/min/mmHg in black, age and 
height matched males compared to matched white females, respectively [17]. Thus the difference 
in DLCO between blacks and whites stem from differences in alveolar volume and hemoglobin 
concentration as there is a ~6% larger hemoglobin concentration in whites compared to blacks 
[17].  Even though DLNO is minimally affected by hemoglobin concentration [24], the 
development of DLNO prediction equations for blacks do seem warrented since there are large 
 
 
3 
 
differences in lung volumes between the two difference ethnic/racial groups. This thesis 
examines DLNO in the younger, adult black population of Atlanta, GA.   
 
Statement of the Problem 
Age, sex, height, and ethnicity/race predict several lung function variables.  Height is the greatest 
predictor of lung volume since about 60% of the variance in vital capacity is shared by height 
[29].  Sex also contributes to a difference in lung volumes as women have about 600 mL lower 
alveolar volume (VA) compared to height and age matched males [29].  Moreover, as mentioned 
previously, there are also ethnic/racial differences in lung volumes [36] and DLCO [11, 17].  The 
reasons for differences in lung volumes between white and blacks are complex, because race is a 
social as well as a biological construct [37].  Even after adjusting for anthropometric, 
socioeconomic, and nutritional variables, there remains a large unexplained portion of the 
differences in vital capacity between blacks and whites [37].  
As there are no prediction equations developed for DLNO in blacks, the development of 
these prediction equations is warranted given the ethnic/racial differences in DLCO. Imagine if a 
prediction equation for diffusing capacity for whites was used in a black population. There could 
be a misdiagnosis of a pathophysiology in the black population since more blacks would be 
below the lower limit of normal for diffusing capacity due to their lower alveolar volumes 
compared to the white population.  Thus, a black individual with normal diffusing capacity 
would be misdiagnosed due to the use of an incorrect prediction equation meant for whites.  
That’s why ethnic/racial specific equations should be made for DLNO.  Furthermore, a 2017 
European Respiratory Society (ERS) Task Force document suggests that reference values are 
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lacking in non-white populations and should be pursued [22]. Thus, the major goal of this study 
was to develop prediction equations for DLNO in a black population.   
Purpose of the study 
The purpose of this study is to develop prediction equations for DLNO and KNO in the black 
population.  Prediction equations for DLNO in the black population are essential so that there is 
a reduced chance for misdiagnosis of lung disease.   
Research questions 
 
1. What is the prediction equation for both DLNO and KNO in a relatively healthy black 
population living in Atlanta, GA? 
2. What is the percent difference in DLNO and VA between blacks and whites matched for 
age, height, and sex? 
Significance of the Study 
 
Prediction equations have been developed for all sorts of lung function tests. These equations are 
necessary to guide pulmonologists in the diagnosis and management of lung disease, so that their 
interpretation of a patient’s lung function can be made more accurately.  The “predicted” value 
of a certain lung function test for a patient’s age, height, sex, and race are compared against the 
patient’s measured value. Creation of such race specific equations will allow for better accuracy 
in determining lung disease, and these values will assist the pulmonologist to formulate the 
proper care plan. By understanding what the lower limit of normal (LLN) is for DLNO for a 
black person of given height, age, and sex, we can understand what are the values below which a 
pathophysiology exists in the group so as to promote better lung health in this population.  If 
abnormal, then appropriate treatment can be determined. Thus, the development of prediction 
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equations for DLNO and KCO in African-Americans are essential to provide accurate predicted 
values.  
Definitions of words or terms 
 
 ATS – American Thoracic Society  
CO – Carbon Monoxide  
ΘCO – specific conductance in the blood for CO [mL CO · (mL blood/min/mmHg)] 
COHb – carboxyhemoglobin 
COPD - Chronic Obstructive Pulmonary Disease 
DL – Diffusing Capacity of the Lung  
DLCO – Diffusing Capacity of the lung for carbon monoxide (mL/min/mmHg) 
DLNO – Diffusing Capacity of the lung for nitric oxide (mL/min/mmHg) 
DMCO – Alveolar-capillary membrane diffusing capacity for CO  
ERS – European Respiratory Society  
FEV1 – Forced expiratory volume in 1 second 
FVC – Forced vital capacity 
FRC – Functional residual capacity 
GSU – Georgia State University 
Hb – Hemoglobin 
KCO – Logarithmic change in CO concentration per unit time and unit pressure (mL 
STPD/min/mmHg/L) and mathematically equivalent to DLCO divided by alveolar 
volume 
NO – Nitric Oxide 
ΘNO – Specific conductance in the blood for NO [mL NO · (mL blood/min/mmHg)] 
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KNO – Logarithmic change in NO concentration per unit time and unit pressure mL 
STPD/min/mmHg/L and mathematically equivalent to DLNO divided by alveolar 
volume 
LLN – Lower limit of normal, taken as the 2.5th percentile  
PFTs – Pulmonary Function Tests  
VA – Alveolar volume (L) 
Vc – Pulmonary capillary blood volume (mL) 
TLC – Total lung capacity (L) 
ULN – Upper limit of normal, taken as the 97.5th percentile 
Assumptions 
It was assumed that at least 100 healthy black male and female subjects from the Atlanta, GA 
area can be recruited. The subjects will vary age, sex and height. It is also assumed that each 
subject will give their best effort during the tests.  Furthermore, it was assumed that each subject 
was truthful in reporting that they were healthy non-smokers with no symptoms of 
cardiopulmonary disease. Finally, it was assumed that the equipment used to measure DLNO is 
functioning adequately.    
Limitations 
The study findings might be affected due to the geographical location of the data collection.  The 
data was collected at one location, Georgia State University (GSU), in Atlanta, GA, and that 
could be a limitation to the study as the results may not be representative of the entire population 
of African-Americans.  It was also difficult to recruit older subjects (>50 years old) as most of 
the subjects that attend GSU are younger (< 29 years old).  
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CHAPTER II 
REVIEW OF THE LITERATURE 
 
The diffusing capacity of the lung (DL) is the measure of the flow of inhaled gas from the 
alveoli to the blood per unit difference in pressure. The total DL is made up of two conductances: 
the diffusing capacity of the alveolar-capillary membrane (DM) and the pulmonary capillary 
volume (Vc) multiplied the specific conductance in the blood for CO (ΘCO). Roughton and 
Forster (1957) demonstrated that the resistance to total oxygen diffusion derived from two 
resistances in series: membrane resistance and red cell resistance such that 1/DLCO = 1/DMCO 
+ 1/(ΘCO·Vc) where DLCO is the pulmonary diffusing capacity for carbon monoxide in 
mL/min/mmHg, DMCO is the alveolar-capillary membrane diffusing capacity for CO in 
mL/min/mmHg, ΘCO is specific conductance in the blood for CO in mL CO·(mL 
blood/min/mmHg), and Vc is the pulmonary capillary blood volume in mL [38].  
In order to obtain DMCO and Vc, a subject inspires a diffusion mixture at two different 
oxygen concentrations and then plot the 1/DLCO results on a graph.  For example, the first 
mixture would be 0.3% CO, 21% O2, 10% He, balance N2, and the subject would calculate 
DLCO from that inspired mixture.  Then the subject would perform another test where he/she 
would inspire a second mixture containing 0.3% CO, 60% O2, 10% He, Balance N2 and the 
subject would calculate DLCO from that mixture. Then the results are plotted:  The y-axis would 
be the inverse of DLCO (1/DLCO), and the x-axis would be 1/ΘCO for each mixture. The slope 
of the two points would be 1/Vc and the y-intercept would be 1/DMCO. Then the inverse of 
1/DMCO and 1/Vc would be the DMCO and Vc, respectively.    
As one can see, calculating DMCO and Vc takes time.  One would need at least two tests 
at the 21% O2 concentration to obtain an average DLCO at that concentration, then another two 
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tests at the 60% O2 concentration to obtain an average at that concentration. Thus, these 4 tests 
would take about 16 minutes of time and there would be a small build-up of CO in the blood.   
However, in the 1980’s, researchers determined that by inhaling a small amount of NO 
together with CO in a single-breath maneuver, one could obtain DLCO and pulmonary diffusing 
capacity for nitric oxide (DLNO) in a single-maneuver, and then interpolate DMCO and Vc from 
that one maneuver [20]. Since that discovery in the 1980’s, there has been much debate on 
whether DMCO and Vc could be determined from this modified Roughton-Forster technique as 
there are a lot of considerations that need addressing [39, 40].  Nevertheless, the latest DLNO 
standardization document published in 2017 has said that it is possible to obtain DMCO and Vc 
using modified Roughton-Forster technique [22].   
One important fact about DLNO is that unlike the DLCO, the main barrier for NO resides 
between the alveolar and red blood cell membranes [23].  Thus, DLNO better represents gas 
transfer through the alveolar-capillary membrane compared to DLCO. This is evident in Figure 1 
of a recent ERS Task Force document on DLNO that demonstrates that only ~25% of the 
resistance to CO diffusion is located in the alveolar-capillary membrane, while ~60% of the 
resistance NO diffusion is located in the alveolar-capillary membrane [22].  Since DLNO is a 
better index of gas transfer though the alveolar-capillary membrane compared to DLCO, a 
measurement of DLNO should be technically superior compared to DLCO in evaluating 
pulmonary disease.   
DLNO is considered to be a better test compared to the DLCO for several reasons. The 
first reason is DLNO is unlike the DLCO, it is a better represents gas transfer through the 
alveolar capillary membrane[22]. Also, unlike the DLCO, the DLNO is unaffected by the 
subject’s hemoglobin concentration [24], carboxyhemoglobin concentration [25] and partial 
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pressure of inspired oxygen (PO2) [26, 41].  However, DLNO is more affected by lung volumes 
changes compared to DLCO [22], thus the DLNO test would be better to examine restrictive 
lung disease that the DLCO test.  There is also evidence to support that DLNO has better 
sensitivity to detect cardiopulmonary disease compared to DLCO [28], and as such, it is about 
time that clinicians use this test routinely [42, 43].     
Nevertheless, in order for DLNO to gain use worldwide, prediction equations need to be 
created.  With the DLCO, predictions have been created been created for adults [2-7] and 
children [8, 9], and over a wide range of racial backgrounds [10-17], no such racially-adjusted 
equation has been developed for DLNO. To date there has been few prediction equations 
developed for single-breath DLNO in adults [29-32] and children [33, 34]. A recent ERS Task 
Force combined data from three studies to create a more accruate model on nearly 500 white 
subjects rangfing from 18 to 93 years old [22]. However, there are no studies to date that has 
created prediction equations for DLNO in the black population.  The main goal of this study is to 
develop prediction equations for DLNO in the black population. 
Table 1 shows the few studies on prediction equations for DLNO in adults and children. 
Nearly all subjects in these studies were performed on the white population from Europe or in 
Canada.  All studies in Table 1 use a combination of age, height and sex in their models to 
predict DLNO.  As Table 1 shows, the models have a relatively good fit in predicting DLNO 
from height, age and sex.  That is ~70% of the variance in DLNO can be predicted by the models 
in Table 1.  
Van der lee et al. (2007) carried out a study to develop reference DLNO [30].  The 
authors selected healthy volunteers from local hospital staff. The inclusion criteria included 
negative history of smoking, no complaints related to respiratory system and negative history 
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about use of any medication. Individuals with serious respiratory or chronic illnesses such as 
diabetes mellitus were excluded. The study enrolled 124 individuals (59 females and 65 males) 
who were undergone plethysmography to determine static and dynamic blood volumes. The 
authors concluded that DLNO is most closely related to membrane diffusion capacity thus 
indicating preferential use of DLNO over DLCO. Aguilaniu et al. (2008) calculated reference 
values for transfer of NO and CO in two European cities; Grenoble (300-m altitude) and 
Bordeaux (30 m altitude) [31]. In the present study 303 individuals were recruited in the range of 
18 to 94 years who underwent single breath technique to measure true diffusion capacity, 
pulmonary capillary blood volume and diffusion capacity for CO and NO. The authors 
concluded that the diffusion capacity was affected by age, sex, height and where the test was 
carried out.  Zavorsky et al. (2008) attempted to develop reference values for DLNO in adult 
white population. The study sample comprised of 130 (66 males and 64 females) individuals 
from young to old age who performed single breath holding maneuvers for a duration of 5 
seconds [29]. Only 20 of these subjects (15%) were ≥ 60 years old.  All subjects were subjected 
to spirometry before participation in the study and 96% of them did not have any signs of 
pulmonary disease a displayed by spirometry. They showed that DLNO was 5x larger than the 
DLCO, with height, sex, and age as significant predictors of DLNO (adjusted R2 = 0.70).  If 
alveolar volume was used instead of height, the model had a higher adjusted R2. 
The most comprehensive model for predicting DLNO was developed using nearly 500 
white subjects ranging from 18 to 93 years old [22]. It was a model based on data from three 
previous studies [29-31]. Height explained 45% of the model, followed by age2 (13%), followed 
by sex (11%).  The full model accounted for 69% of the variance in DLNO.  The LLN (2.5th 
percentile) and ULN (97.5th percentile) was developed and presented as an on-line supplement 
 
 
11 
 
[22]. The model demonstrates that the LLN and ULN for DLNO are ± 39.2 mL/min/mmHg 
below and above the predicted values, respectively [22]. For DLCO, the LLN and ULN for were 
± 8.2 mL/min/mmHg below and above the predicted values, respectively [22]. 
While it is recommended that a 10 seconds breath-hold time for DLNO tests be used for 
better gas mixing [22], a 4-6 seconds breath-hold time can be acceptable if using a less sensitive 
NO electrochemical cell [22]. In the comprehensive prediction model for DLNO [22], the breath-
hold time was ~6 seconds, and the inspired oxygen and NO concentration was 19.5% (SD 0.7%), 
and 35 (12) ppm, respectively [22].  
In Table 2, the prediction equations for DLCO are presented for comparison to DLNO. 
Table 2 demonstrates that DLNO and DLCO follow each other closely.  There is an approximate 
90% shared variance between DLNO and DLCO [22], with the DLNO being 4.6 to 4.8x larger 
than the DLCO in healthy white subjects [22]. In subjects with various cardiopulmonary 
diseases, the percentage shared variance between DLNO and DLCO drops to 62% [28].  
Furthermore, when there is a mean reduction in DLCO compared to healthy controls, DLNO is 
reduced similarly [28]. Finally, DLNO is more affected by lung volume changes than the DLCO. 
For a 50% reduction is alveolar volume, DLCO is only reduced by ~25%, while, DLNO is 
reduced by ~40% [22].  These results suggest, DLNO is a better indicator of gas transfer in those 
with restrictive lung disease.   
Vital capacity (i.e. lung volume) is about 15% lower in blacks compared to age, height, 
and sex matched whites [11, 36]. The DLCO is also lower in matched whites [11, 17].  These 
predictors demonstate the need for racial specific equations for DLNO.  Studies demonstrate that 
DLCO is lower by ~2 (~6%) and ~5 (~15%) mL/min/mmHg in black, age and height matched 
males compared to matched white females, respectively [17]. Thus the difference between blacks 
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and whites is mostly from lung volume differences, but also from hemoglobin differences as 
there is a ~6% larger hemoglobin concentration in whites compared to blacks [17].  Previous 
work has shown that DLNO is minimally affected by hemoglobin concentration [24], so the 
hemoglobin differences between blacks and whites should be inconsequential in the development 
of DLNO prediction equations for blacks. However, DLNO prediction equations are warrented 
since lung volume differences must be accounted for between the two ethnic/racial groups. 
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CHAPTER III 
METHODOLOGY 
 
Healthy black male and female non-smoking adults from Georgia State University (GSU) were 
recruited by word of mouth and through the posting of flyers to participate in one testing session 
involving the measurement of various lung parameters including DLNO and DLCO at the Petit 
Science Center (room 457) at GSU. This study was performed in conjunction with another study 
examining the six-minute walk test in this same ethnic/racial group and was approved by the 
Georgia State University ethics board (IRB #H16120, Reference # 335588).  The inclusion and 
exclusion criteria was as follows: 
Inclusion criteria: 
 Apparently healthy, black, non-smoking and non-pregnant individuals’ ≥ 18 years of age, 
with a body mass index (BMI) ranging from 17.0 to 34.9 kg/m2. Non-smoking will be 
defined as never smoked or quit smoking > 6 months previously.  
 These subjects did not have cardiopulmonary disease or they will be absent of major 
signs/symptoms suggestive of cardiopulmonary disease [44].  
Exclusion criteria:  
 Individuals who were less than 18 years of age, who are not black, or have a BMI < 17.0 
or ≥ 35.0 kg/m2, or are currently smoking or ceased smoking within the previous six 
months, or who are pregnant.  
 Have cardiopulmonary disease, or presence of major signs/symptoms suggestive of 
cardiopulmonary disease [44],  
 Have chest or abdominal pain or any cause, oral or facial pain exacerbated by a 
mouthpiece, stress incontinence, dementia or in a state of confusion [45].  
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Procedures 
The study was conducted at Room 457 of the Petit Science Center and the procedures lasted 
approximately 1.75 hours per subject. Subjects signed an informed consent form to participate in 
the study. Subjects filled out a questionnaire about their date of birth, sex, as well as physical 
activity readiness questionnaire (PAR-Q) and a health questionnaire. Then height, weight, waist 
and hip circumference was measured. After those parameters were obtained, heart rate was 
measured via a POLAR A300 heart rate monitor (Polar Electro Oy, Kempele, Finland) during 
the pulmonary function tests. The average heart rate recorded during these lung function tests 
(i.e. 20-30 minutes) was used for data analyses.  
Several pulmonary function tests were performed: spirometry, slow vital capacity, total 
lung capacity, pulmonary diffusing capacity, maximal inspiratory (MIP) and expiratory pressures 
(MEP). The procedures, rules, and established safety for conducting these lung function test are 
described elsewhere [46-50].  The diffusing capacity test involved subjects inspiring about 4 to 6 
liters of a standard diffusion gas mixture that is used for diagnostic purposes including a small 
amount of NO (i.e. 0.3% CO, 21% O2, 10% He, 40-60 ppm NO, Balance N2). This gas is inhaled 
once for 5 to 10 seconds at total lung capacity, and then exhaled. 
The Hyp’Air discrete lung diffusion system (Medisoft Inc., Dinant, Belgium) was used 
for the assessment of DLNO and DLCO using the 5 second breath-hold maneuver.  The Medisoft 
/ Morgan Scientific Bodybox (Plethsymograph, model 5550) was used for the assessment of 
spirometry, TLC, and DLCO using the 10 s breath-hold maneuver. The best values for 
spirometry were reported [46], and the mean value for DLNO and DLCO was reported when the 
two highest DLCO values varied by not more than 3 mL/min/mmHg and the two highest DLNO 
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values did not vary by more than 17 mL/min/mmHg [22].  For the measurement of TLC from the 
body box, three values for FRC that agreed within 5% was obtained, and the mean reported [48].   
All data were manually recorded on specially formatted collection sheets which was 
stored at a secure location in PSC 457.  This lab was locked with access granted only to the 
faculty advisor and student researchers. Electronic backup of information was provided by the 
investigators on excel spreadsheets on password protected computers, locked inside PSC 457. 
Subjects were paid $30 for their participation. The funding for this study came from the Jerome 
M. Sullivan Research Fund from the American Respiratory Care Foundation. 
Calculation of DLNO, DLCO, DMCO, and Vc 
The DLNO and DLCO was calculated using the recommended guidelines from the ATS and 
ERS [22, 51]. The DMCO and Vc were estimated by using the ΘCO formula from Guénard and 
colleagues [27], the ΘNO of 4.5 mL NO·(mL blood/min/mmHg) from Carlson and Comroe [52], 
the DMNO/DMCO ratio of 1.97, a standardized women’s hemoglobin concentration of 13.4 
g/dL, a standardized men’s hemoglobin concentration of 14.6 g/dL, and a PAO2 of 100 mmHg, as 
recommended by the ERS Task Force [22]. 
Statistical analyses 
Spirometry values (FVC, FEV1, FEV1/FVC ratio) was compared to predicted values for the 
black population [36]. Total lung capacity was compared to the predicted values for a white 
population [3].  The mean predicted values were compared to the mean measured values via a 
paired t-test.  In prediction studies, the number of subjects should be sufficiently large because 
the larger the sample, the more likely it will be to represent the population.  It is known that there 
is a direct relationship between the correlation and the ratio of the number of variables in the 
model (k) to the number of participants in the model (n), such that (k – 1) ÷ (n – 1) [53]. Thus, if 
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a study has 40 participants and 30 variables, the R2 would be 0.74 based on chance alone and the 
results would be meaningless. Thus, it is recommended that there be at least a 10:1 participant to 
variable ratio to avoid this error [53]. Furthermore, another formula used: n ≥ 50 +8·k  also 
predicts the number of subjects needed to develop a reliable equation [54]. So in this case, where 
there are five potential predictors for DLNO (age, age2, the interaction term age·age2, sex, 
weight, height), at least 60 to 98 subjects would be needed.  
A multiple linear regression using the stepwise procedure was conducted to determine 
which independent variable DLNO (age, age2, the interaction term age·age2, sex, weight, height) 
were predictors of DLNO (first dependent variable), KNO, (second dependent variable) and 
alveolar volume (third main dependent variable). Since regression is very sensitive to extreme 
cases, outliers were removed.  Any data point that exceeded the chi-square criteria (standard 
deviation of the residuals > 3.0) was eliminated. Then, linearity was analyzed by creating a 
scatterplot matrix of the variables age, age2, DLNO, KNO, weight, and height. Another plot was 
created between the standardized residuals (y-axis) and standardized predicts (x-axis) to see if 
the values will be consistently spread out, which would indicate normality and homoscedasticity. 
The lower limit of normal (LLN) will be calculated by multiplying the standard error of the 
estimate by 2.0 and then subtracting that number from the prediction1. This value would 
represent the 2.5th percentile according to t-tables. Any patient that has a value below LLN was 
considered a true pathophysiological abnormality in diffusing capacity. The upper limit of 
normal (ULN) was calculated by multiplying the standard error of the estimate by 2.0 and adding 
it to the prediction1. This value would represent the 97.5th percentile according to t-tables. Any 
patient that has a value above the ULN would indicate a clinically meaningful increase in 
                                                     
1 When the Degrees of Freedom is 60, the z-score is not ± 1.96 for the 2.5th and 97.5th percentiles, it is ± 2.00.  
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diffusing capacity above predicted, which signifies genetically superior alveolar-capillary 
membrane diffusion capability. A Type I probability level of 0.05 will be used. Statistical 
software utilized for this project will be IBM SPSS Statistics Version 21.0, Chicago, IL.  
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CHAPTER IV 
RESULTS 
 
Fifty-nine adult black subjects were recruited from GSU over a period of six months in 2016 
(Table 3).  All the fifty-nine subjects (32 females, 27 males) completed all tests.  The subjects 
ranged from 18 to 67 years of age and the mean resting heart rate was 80 (SD 10) beats/min.  
The breakdown of the age categories was as follows: 18 to 29 years old (17 males and 18 
females), 30 to 39 years old (7 males and 4 females), 40 to 49 years old (2 males and 7 females), 
50 to 59 years old (1 male and 1 female), 60-69 years old (0 male and 2 females) with a BMI 
ranging from 17 to 32 kg/m2. Only 22% of the subjects were ≥ 40 years old. All the subjects 
claimed to be healthy with no previous cardiac or pulmonary issues. Most subjects had normal 
spirometric function for their race.  However, five subjects (8%) of the subjects did have mild 
obstructive issues as determined by the FEV1/FVC being below the LLN (Table 4).   
The DLNO using the five second breath-hold (DLNO5s) ranged from 71 to 205 
mL/min/mmHg (Table 5). The DLCO using the five second breath-hold (DLCO5s) and 10 
second breath-hold (DLCO10s) were similar and ranged from about 16 to 45 mL/min/mmHg 
(Table 5). The inspired NO and oxygen concentration from the DLNO5s was 43 (4) ppm, and 
19.7 (0.12) %, respectively (Table 6).  The mean DLCO5s values were not statistically different 
compared to the mean DLCO10s values (Table 7); although VA was statistically larger, by 150 
mL (3%) in the DLCO5s test (Table 7). The DLNO5s was about 5x larger than the DLCO5s (Table 
2).   
Prediction equations for DLNO and the components of DLCO are presented in Table 8.  
About 77% of the variance in DLNO was accounted for by sex (67%), age2 (7%), and height 
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(4%).  Interestingly, both DLNO and DLCO negatively correlated with resting heart rate (Figure 
1), but the heart rate was not included in any of the models due to its poor predictive value.  
As expected, the prediction equations in the black population (Table 8) yielded lower 
predicted DLNO, KNO and VA compared to the ERS prediction equations [22]. When compared 
to whites of the same age and height, black males had a 7-10% lower DLNO, and black females 
had a 12-15% lower DLNO (Table 9). Black males of the same age and height had a 10% 
smaller alveolar volume, while black females had a 15% lower alveolar volume compared to 
matched whites (Table 9).   
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CHAPTER V 
DISCUSSION 
 
The purpose of this study was to develop prediction equations for DLNO and KNO in healthy 
adult black subjects. The development of prediction equations in this ethnic/racial group was a 
response to a recent ERS Task Force document citing its need [22]. To date, there are no 
published papers on prediction equations for DLNO in this ethnic/racial group.  These are the 
first predictions equations ever developed for the black population.    
 Overall, data collection was performed adequately. Mean inspired volumes were 94% of 
the FVC during the DLCO10s and 89% of the FVC for the DLNO5s test. The mean VA measured 
from DLCO10s and DLCO5s was 91% and 88% of the measured TLC from the Bodybox, 
respectively.  
The data demonstrates that black males have a DLNO5s that is 34 mL/min/mmHg higher 
than black females. This is a similar difference between the sexes in white subjects [22]. For 
every one cm increase in height, DLNO5s increases similarly in the white (0.8 mL/min/mmHg 
per cm) [22] and black population (0.9 mL/min/mmHg per cm) (Table 8). However, only 59 
subjects were studied, and most of the subjects were < 40 years of age, so the comparison of 
slopes between ethnic/racial groups are only accurate up to 40 years of age.  
Studies demonstrate that DLCO10s is lower by ~2 (~6%) and ~5 (~15%) mL/min/mmHg 
in black, age and height matched males compared to matched white females, respectively [17], 
due to mostly, differences in lung volumes between the two ethnic/racial groups. We also found 
that the predicted DLNO in the male black population was 7% to 10% lower compared to the 
predicted value for the age and height matched white male population. In the female black 
population, DLNO was 12 to 15%  compared to the predicted value for the age and height 
matched white female population. And these differences was largely due to a 10% (male) to 15% 
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(female) smaller predicted alveolar volume in blacks compared to whites. This shows that if a 
prediction equation for DLNO for whites was used in a black population, there would be a 
misdiagnosis of poor gas transfer in the lung in 12 to 15% of the black population, and that is 
because of the lower alveolar volumes in blacks compared to sex, age, and height matched 
whites.  That’s why ethnic/racial specific equations must be made for DLNO.   
In the future, it will be interesting to see the comparisons of DLNO prediction equations 
with other racial/ethnic groups including mixed-race groups. As one can see, there there is a lot 
of work that still needs to be done.  
Limitations 
We were only able to obtain data on 59 subjects due to several factors. First, there was great 
difficulty in finding subjects ≥ 40 years of age.  Second, the HYP’Air pulmonary function 
system needed repair and thus we were not able to collect data for two months.  However, we are 
confident that the DLNO prediction equation works well in subjects < 40 years of age as ~80% 
of the subjects were below 40 years of age.  
Conclusion 
The development of racially-adjusted prediction equations for DLNO can help prevent 
misdiagnosis of lung disease.  Racially-adjusted prediction equations for DLNO allows clinicians 
to make a more accurate interpretation of a patient’s lung function which will lead to a better 
diagnosis and management of lung illnesses. In this study, about 77% of the variance in DLNO 
was accounted for by sex (67%), age2 (7%), and height (4%). Also, the prediction equations in 
the black population yielded lower predicted DLNO, KNO, and VA compared to the prediction 
equations developed for white subjects [22]. Black males had a 7-10% lower DLNO, and black 
females had a 12-15% lower DLNO compared to matched white subjects. Black males of the 
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same age and height had a 10% smaller alveolar volume, while black females had a 15% lower 
alveolar volume compared to matched whites.  Heart rate was negatively associated with DLNO 
and DLCO. Finally, the regression model presented predicted DLNO in black subjects, but only 
the model was only accurate in those below 40 years of age.  The addition of older black subjects 
to this model in the future will help make this prediction equation more useful.   
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LIST OF TABLES 
 
Table 1. DLNO5s prediction equations for white subjects. 
 
Study Prediction equation for DLNO5s BHT Number 
of 
subjects 
R2 SEE 
Adults (White 
subjects) 
     
van der Lee et al. 
(2007) 
(mmoL/min/kPa) 
Females 
0.5347· (height in cm) – 0.077·(age) 
– 48.28 
10s 59 F -- 5.22 
van der Lee et al. 
(2007) 
(mmoL/min/kPa) 
Males 
0.5984· (height in cm) – 0.25·(age) – 
44.20 
10s 65 M -- 6.39 
Aguilaniu et al. 
(2008) 
(mL/min/mmHg) 
>59 years old 
1.365· (height in cm) – 0.90 · (age) + 
27.35·(Sex) – 54.69 
4 s 59 F 
45 M 
0.72 -- 
Aguilaniu et al. 
(2008) 
(mL/min/mmHg) 
≤ 59 years old 
1.365· (height in cm) – 0.88 · (age) + 
27.35·(Sex) – 54.69 
4 s 59 F 
45 M 
0.72 -- 
Zavorsky et al. 
(2008) 
(mL/min/mmHg) 
1.17· (height in cm) – 1.21 · (age) + 
31.81·(Sex) – 20.1 
5s 64 F 
66 M 
0.70 20.2 
Zavorsky et al. 
(2017) 
(mL/min/mmHg) 
 
0.81· (height in cm) – 0.010·(age2) + 
34.4 · (sex) + 9.7 
 
6s  242 F 
248 M 
0.69 20.0 
Children (white 
subjects) 
     
Thomas et al. 
(2014) 
(mmoL/min/kPa) 
 
Exp [1.3145 + 0.0214·(age) – 
0.0058·(sex) + 0.0119· (height in 
cm) – 1.2893·10-8 · (height in cm)3 + 
2.7070·10-8·(Sex) · (height in cm)3] 
5s 312 -- -- 
BHT = breath-hold time (s); SEE = standard error of the estimate; Sex (1 = male, 0 = female). 
Note: There were prediction equations developed by Rouatbi et al. (2010) for North-African 
adults where DmCO and Vc were estimated based on DLCO and DLNO [32].  However, no 
actual prediction equations for DLNO were found in that article. As such, Rouatbi’s paper using 
for North-African adults is not included in this table.  
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Table 2. DLCO5s prediction equations for white subjects.  
 
Study Prediction equation for DLCO5s BHT Number 
of 
subjects 
R2 SEE 
Adults (White)      
van der lee et al. 
(2007) 
(mmoL/min/kPa) 
Females 
10.51· (height in m) – 0.030·(age) – 
7.43 
10s 59 F -- 1.37 
van der lee et al. 
(2007) 
(mmoL/min/kPa) 
Males 
12.02· (height in m) – 0.074·(age) – 
6.88 
10s 65 M -- 1.74 
Aguilaniu et al. 
(2008) 
(mL/min/mmHg) 
>59 years old 
29.291· (height in m) – 0.262 · (age) 
+ 5.044·(Sex) – 12.954 
4 s 59 F 
45 M 
0.73 -- 
Aguilaniu et al. 
(2008) 
(mL/min/mmHg) 
≤ 59 years old 
29.291· (height in m) – 0.161 · (age) 
+ 5.044·(Sex) – 12.954 
4 s 59 F 
45 M 
0.73 -- 
Zavorsky et al. 
(2008) 
(mL/min/mmHg) 
0.214· (height in cm) – 0.242 · (age) 
+ 5.94·(Sex) – 1.3 
5s 64 F 
66 M 
0.69 4.0 
Zavorsky et al. 
(2017) 
(mL/min/mmHg) 
 
0.23· (height in cm) – 0.002·(age2) + 
6.0 · (sex) – 8.5 
 
6s  242 F 
248 M 
0.68 4.2 
Children (white)      
Thomas et al. 
(2014) 
(mmoL/min/kPa) 
Exp [0.9440 + 0.0205·(age) + 
0.0908·(sex) + 1.6233·10-7 · (height 
in cm)-3] 
5s 312 -- -- 
BHT – breath-hold time (s); Sex (1 = male, 0 = female).   Note: There were prediction equations 
developed by Rouatbi et al. (2014) for North-African children where DmCO and Vc were 
estimated based on DLCO and DLNO [34].  However, no actual prediction equations for DLNO 
were found in that article. As such, Rouatbi’s paper using North African children is not included 
in this table. 
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Table 3. Anthropometric characteristics of the subjects including age. 
 
 Males (n = 27) Females  
(n = 32) 
Combined 
(n = 59) 
Age (years) 28 (10) 
[18 to 55] 
 
32 (14) 
[20 to 67] 
30 (12) 
[18 to 67] 
Weight (kg) 78.6 (11.1) 
[61 to 102.4] 
 
68.3 (13.9) 
[47.8 to 95.7] 
73.0 (13.6) 
[47.8 to 
102.4] 
Height (cm) 176.2 (6.7) 
[163.1 to 189.4] 
 
163.2 (6.7) 
[140.2 to 180.0] 
169 (10) 
[140 to 189] 
Body mass index (kg/m2) 25.3 (2.9) 
[18.8 to 30.6] 
 
25.3 (4.4) 
[17.2 to 32.3] 
25.3 (3.8) 
[17.2 to 32.3] 
Waist Circumference (cm) 83.7 (8) 
[66 to 100] 
82.3 (11) 
[65 to105] 
82.9 (9.7) 
[65 to 105] 
Hip Circumference (cm) 101.8 (6.9) 
[90.5 to 119.0] 
 
102.5 (9.6) 
[87.6 to 119.0] 
102.2 (8.4) 
[87.6 to 119] 
WHR 0.82 (0.04) 
[0.72 to 0.90] 
 
0.80 (0.06) 
[0.69 to 0.96] 
0.81 (0.05) 
[0.69 to 0.96] 
Mean (SD). Brackets represent the range. Body mass index (BMI) is calculated weight (Kg) 
divided by height2 (meters).  
 
 
Table 4. Spirometric results of the subjects.  
5 of 59 subjects (~8%) demonstrated a mild obstructive pattern based on being below the LLN 
for FEV1/FVC. The % predicted for FVC, FEV1, and FEV1/FVC was from The Global Lung 
Function Initiative prediction equations for blacks [36]. The  % predicted TLC was from white 
prediction equations from Verbanck and colleagues [3].    
 Mean value 
 
% predicted p-value 
SVC (L) 
 
4.16 (0.94) -- -- 
FVC (L) 
 
4.20 (0.91) 111 (11) 0.000 
FEV1 (L) 
 
3.48 (0.72) 109 (13) 0.000 
FEV1/FVC 
 
0.83 (0.07) 98 (7) 0.014 
TLC (L) 
 
5.82 (1.24) 99 (11) 0.529 
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Table 5. Pulmonary diffusing capacity results. 
 
 Males 
(n = 27) 
Females 
(n = 32) 
Combined 
(n = 59) 
Hyp’Air (5 s BHT) 
 
DLNO 
(mL/min/mmHg) 
165 (23) 
[120 to 205] 
110 (162) 
[71 to 138] 
135 (34) 
[71 to 205] 
DLCO 
(mL/min/mmHg) 
32.9 (5.0) 
[23.1 to 43.9] 
21.4 (2.6) 
[16.6 to 27.0] 
26.6 (7) 
[16.6 to 43.9] 
DMCO 
(mL/min/mmHg) 
169 (29) 
[127 to 238] 
107 (26) 
[54 to 192] 
136 (42) 
[54 to 238] 
Vc (mL) 73 (13) 
[50 to 103] 
52 (7) 
[44 to 69] 
62 (14) 
[44 to 103] 
VA(L) 6.2 (0.9) 
[5.8 to 7.9] 
4.5 (0.7) 
[3.1 to 6.3] 
5.3 (1.2) 
[3.1 to 7.9] 
DmCO/VA ratio 
(mL/min/mmHg/L) 
27.4 (4.5) 
[19.8 to 35.2] 
23.8 (5.1) 
[16.7 to 36.7] 
25.5 (5.1) 
[16.7 to 36.7] 
KCO(mL/min/mmHg/L) 5.3 (0.8) 
[3.5 to 6.7] 
4.8 (0.6) 
[3.6 to 6.0] 
5.0(0.8) 
[3.5 to 6.7] 
KNO(mL/min/mmHg/L) 26.7 (3.8) 
[18.6 to 32.9] 
24.6 (3.3) 
[18.3 to 29.6] 
25.5 (3.6) 
[18.3 to 32.9] 
DLNO/DLCO ratio 5.0 (0.3) 
[4.3 to 5.5] 
 
5.1 (0.4) 
[4.3 to 6.3] 
5.1 (0.4) 
[4.3 to 6.3] 
Bodybox (10 s BHT) 
 
DLCO 
(mL/min/mmHg) 
32.6 (4.0) 
[26.6 to 44.6] 
21.5 (2.3) 
[16.4 to 26.8] 
26.6 (6.4) 
[16.4 to 44.6] 
VA (L) 6.0 (0.8) 
[4.5 to 8.4] 
4.4 (0.7) 
[3.1 to 5.9] 
5.1 (1.1) 
[3.1 to 8.4] 
KCO(mL/min/mmHg/L) 5.5 (0.8) 
[3.4 to 7.4] 
5.0 (0.8) 
[3.4 to 6.8] 
5.2 (0.8) 
[3.4 to 7.4] 
TLC (L) 6.8 (1.0) 
[5.0 to 9.3] 
5.0 (0.7) 
[4.0 to 7.0] 
5.8 (1.2) 
[4.0 to 9.3] 
Mean (SD). Brackets represent the range. 
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Table 6. Inhaled and exhaled gases including breath-hold time (BHT) for both PFT machines 
(Hyp’Air and BodyBox).  
 
 O2 CO He NO BHT 
Inspire Expire Inspire Expire Inspire Expire Inspire Expire 
Hyp’Air 19.7 
(0.12) 
 
16.8 
(0.54) 
0.30 
(0.00) 
0.10 
(0.02) 
9.5 
(0.6) 
6.0 
(0.6) 
43 (4) 4 (1.0) 5.6  
(0.6) 
BodyBox 20.7 
(2.4) 
 
17.7 
(0.6) 
0.30 
(0.01) 
0.10 
(0.01) 
10 
(0.1) 
7.0 
(0.6) 
-- -- 10.3  
(0.5) 
Mean (SD) 
 
 
 
 
 
Table 7. The differences in DLCO between the two PFT systems using two different breath-hold 
times. 
 
 BodyBox (10s BHT) Hyp’Air (5s BHT) ∆ P value 
VA (L) 
 
5.1 (1.1) 5.3 (1.2) -0.15 (0.4) 0.004 
DLCO (L) 
 
26.6 (6.4) 26.6 (7.0) -0.1 (3.1) 0.868 
Inspired 
volume (L) 
3.95 (0.86) 3.72 (0.84) 0.24 (0.28) 0.000 
Mean (SD). BHT = breath-hold time. 
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Table 8. Predictive equations for healthy black adults using a 5 s breath-hold (Hyp’Air PFT 
system) for DLNO and DLCO, and 10 s breath-hold (Bodybox) for DLCO. 
 
 Height 
(cm) 
Age2 Sex Constant Adjusted 
R2 
SEE LLN 
and 
ULN 
Hyp’Air (5s BHT) 
DLNO 
(mL/min/mmHg) 
0.92 –  0.012 38.8 – 25.2 0.77 16.3 ± 32.6 
DLCO 
(mL/min/mmHg) 
-- – 0.002 11.0 23.3 0.72 3.7 ± 7.4 
DMCO 
(mL/min/mmHg) 
1.66 – 0.016 35.6 – 143.9 0.71 22.3 ± 44.6 
Vc  
(mL) 
-- – 0.003 19.7 56.3 0.55 9.6 ± 19.2 
VA 
(L) 
0.056 -- 1.0 – 4.61 0.69 0.64 ± 1.28 
Vc/VA 
(mL/L) 
-0.11 – 0.001 1.32 30.3 0.26 1.7 ± 3.4 
DMCO/VA  
(mL/min/mmHg/L) 
1.32 – 0.04 -- 6.9 0.41 4.0 ± 8 
KCO 
(mL/min/mmHg/L) 
– 0.034 – 0.00033 0.87 10.8 0.51 0.6 ± 1.2 
KNO 
(mL/min/mmHg/L) 
-- – 0.00264 -- 28.31 0.43 2.8 ± 5.5 
BodyBox (10s BHT) 
DLCO 
(mL/min/mmHg) 
-- -- 11.14 21.46 0.75 3.2 ± 6.4 
VA (L) 0.06 -- 0.89 -5.41 0.72 0.59 ± 1.18 
KCO 
(mL/min/mmHg/L) 
--  – 0.000394 -- 5.62 0.176 0.74 ± 1.48 
 SEE = standard error of the estimate. Age is in years; height is in cm. Sex = 1 for males, 0 for 
females.  
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Table 9. Difference in predicted DLNO, KNO, and VA between blacks and whites of the same 
age. 
 
 25 years of age and 175 cm tall 45 years of age and 175 cm tall 
 DLNO (males) DLNO 
(females) 
DLNO (males) DLNO 
(females) 
Whites  180 145 166 131 
Blacks 167 128 150 112 
Difference 13 17 14 19 
% Difference 7% 12% 10% 15% 
     
 25 years of age and 175 cm tall 45 years of age and 175 cm tall 
 VA (males) VA (females) VA (males) VA (females) 
Whites  6.9 6.1 6.9 6.1 
Blacks 6.2 5.2 6.2 5.2 
Difference 0.7 0.9 0.7 0.9 
% Difference 10% 15% 10% 15% 
     
 25 years of age and 175 cm tall 45 years of age and 175 cm tall 
 KNO (males) KNO (females) KNO (males) KNO (females) 
Whites  25.5 25.5 23.6 23.6 
Blacks 26.7 26.7 23.0 23.0 
Difference 1.2 1.2 0.6 0.6 
% Difference 5% 5% 3% 3% 
For blacks, the prediction equations used were from Table 8. For whites, the prediction equations 
used were from the ERS Task Force document [22]. DLNO is measured in mL/min/mmHg, VA 
is measured in L, and KNO is measured in ml/min/mmHg/L.  
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Figure 1. The association between resting heart rate (HR) and diffusing capacity. 
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